Medicaid does not have to cover these, though some state programs do
Semaglutide, through its action on the GLP-1 receptors, not only assists in weight reduction by regulating appetite and food intake but also shows promise in sustaining weight loss over extended periods when combined with lifestyle modifications like diet and exercise
2.8% said they used them for 11 months
You see a viral TikTok, click a link, and suddenly you are buying a product without knowing whether it fits your medication, digestion, goals, or taste preferences
Quarterly injections could be on the horizon (3-5 years) if human studies back up what the animal models predict
So Part D is still central to the Bridge as an eligibility requirement, even though the plan-based BALANCE coverage is not happening for now